ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 46 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,480 | -79.9% | 10,912 | -72.4% | 0.00% | – |
Q2 2023 | $141,500 | +58.7% | 39,525 | -3.4% | 0.00% | – |
Q1 2023 | $89,173 | -94.4% | 40,905 | -69.2% | 0.00% | -100.0% |
Q4 2022 | $1,599,906 | +488.2% | 132,993 | +216.8% | 0.00% | – |
Q3 2022 | $272,000 | -19.0% | 41,985 | -42.8% | 0.00% | – |
Q2 2022 | $336,000 | -53.8% | 73,414 | -12.7% | 0.00% | – |
Q1 2022 | $728,000 | -71.2% | 84,119 | -52.4% | 0.00% | – |
Q4 2021 | $2,525,000 | -46.3% | 176,740 | -17.4% | 0.00% | -100.0% |
Q3 2021 | $4,702,000 | +713.5% | 213,910 | +395.0% | 0.00% | – |
Q2 2021 | $578,000 | +572.1% | 43,211 | +113.0% | 0.00% | – |
Q4 2020 | $86,000 | +1.2% | 20,291 | -38.0% | 0.00% | – |
Q3 2020 | $85,000 | +16.4% | 32,735 | +59.4% | 0.00% | – |
Q2 2020 | $73,000 | -62.8% | 20,542 | -46.0% | 0.00% | – |
Q4 2019 | $196,000 | +164.9% | 38,067 | +64.9% | 0.00% | – |
Q3 2019 | $74,000 | -52.3% | 23,085 | -46.6% | 0.00% | – |
Q2 2019 | $155,000 | -11.9% | 43,212 | +189.1% | 0.00% | -100.0% |
Q1 2014 | $176,000 | – | 14,948 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 366,401 | $2,374,000 | 2.07% |
Private Portfolio Partners LLC | 67,400 | $436,752 | 0.12% |
Knoll Capital Management, LLC | 20,000 | $130,000 | 0.08% |
ETF MANAGERS GROUP, LLC | 94,493 | $612,000 | 0.02% |
Virtu Financial LLC | 21,526 | $139,000 | 0.01% |
OCCUDO QUANTITATIVE STRATEGIES LP | 21,904 | $142,000 | 0.01% |
BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $36,000 | 0.01% |
Walleye Capital LLC | 78,418 | $508,000 | 0.01% |
Jump Financial, LLC | 36,100 | $234,000 | 0.01% |
Plante Moran Financial Advisors, LLC | 7,911 | $51,000 | 0.01% |